NO974837D0 - Terapeutisk preparat omfattende et antigen eller en in vivo-generator for generering av en forbindelse som omfatter en aminosyre-sekvens - Google Patents

Terapeutisk preparat omfattende et antigen eller en in vivo-generator for generering av en forbindelse som omfatter en aminosyre-sekvens

Info

Publication number
NO974837D0
NO974837D0 NO974837A NO974837A NO974837D0 NO 974837 D0 NO974837 D0 NO 974837D0 NO 974837 A NO974837 A NO 974837A NO 974837 A NO974837 A NO 974837A NO 974837 D0 NO974837 D0 NO 974837D0
Authority
NO
Norway
Prior art keywords
antigen
compound
generating
amino acid
acid sequence
Prior art date
Application number
NO974837A
Other languages
English (en)
Other versions
NO974837L (no
Inventor
Vincent Ganne
Original Assignee
Seppic Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seppic Sa filed Critical Seppic Sa
Publication of NO974837D0 publication Critical patent/NO974837D0/no
Publication of NO974837L publication Critical patent/NO974837L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO974837A 1995-04-20 1997-10-20 Terapeutisk preparat omfattende et antigen eller en in vivo-generator for generering av en forbindelse som omfatter en aminosyre-sekvens NO974837L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9504739A FR2733151B1 (fr) 1995-04-20 1995-04-20 Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
PCT/FR1996/000609 WO1996032964A1 (fr) 1995-04-20 1996-04-22 Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines

Publications (2)

Publication Number Publication Date
NO974837D0 true NO974837D0 (no) 1997-10-20
NO974837L NO974837L (no) 1997-10-20

Family

ID=9478297

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974837A NO974837L (no) 1995-04-20 1997-10-20 Terapeutisk preparat omfattende et antigen eller en in vivo-generator for generering av en forbindelse som omfatter en aminosyre-sekvens

Country Status (12)

Country Link
US (5) US6274149B1 (no)
EP (1) EP0825875B1 (no)
JP (2) JP3455226B2 (no)
KR (1) KR19990007883A (no)
CN (1) CN1088599C (no)
AU (1) AU695802B2 (no)
BR (1) BR9608067A (no)
DE (1) DE69608962T2 (no)
ES (1) ES2147924T3 (no)
FR (1) FR2733151B1 (no)
NO (1) NO974837L (no)
WO (1) WO1996032964A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707896B1 (fr) * 1993-07-22 1995-09-01 Chemoxal Sa Procédé de traitement d'un article et nouvelle solution aqueuse de peroxyde d'hydrogène.
FR2754715B1 (fr) * 1996-10-18 1998-11-13 Seppic Sa Adjuvant, notamment sous forme d'une emulsion contenant un cation metallique trivalent et composition vaccinale le comprenant
US6689370B1 (en) * 1995-04-20 2004-02-10 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US6117432A (en) * 1995-04-20 2000-09-12 Societe D'exploitation De Produits Pour Les Industries Chimiques (S.E.P.P.I.C.) Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence
FR2754182B1 (fr) * 1996-10-07 1998-11-06 Seppic Sa Nouvelles compositions vaccinales comportant comme adjuvant un compose sympathomimetique
US6524592B2 (en) * 1997-10-17 2003-02-25 American Home Products Corporation Veterinary vaccines
WO2000051634A1 (fr) * 1999-03-03 2000-09-08 The Kitasato Institute Preparations de vaccins contenant des acides gras comme composants
FR2800280B1 (fr) * 1999-10-29 2003-09-19 Seppic Sa Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite
KR20000024614A (ko) * 2000-02-23 2000-05-06 이기창 휴대 전화기와 음향기기를 함께 사용할 수 있는 스테레오핸즈프리 송수화기 및 전환 제어장치
FR2809961B1 (fr) * 2000-06-09 2004-12-03 Seppic Sa Utilisation d'ethers de sucres, comme adjuvants d'immunite dans les compositions vaccinales, compositions therapeutiques les renfermant et leur utilisation comme vaccins
CA2420601A1 (en) 2000-08-31 2003-02-26 The Kitasato Institute Vaccine preparation containing fatty acid as component
FR2814956B1 (fr) 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
WO2002028424A2 (en) * 2000-10-06 2002-04-11 Paradies H Henrich Kyberdrug as autovaccines with immune-regulating effects
AU2002233557A1 (en) * 2001-03-05 2002-09-19 Forinnova As Immune response potentiation
GB0218821D0 (en) * 2002-08-13 2002-09-18 Glaxosmithkline Biolog Sa Novel compositions
DK1613346T3 (da) * 2003-04-04 2013-01-07 Pah Usa 15 Llc Mikrofluidiske olie-i-vand-emulsioner og vaccinesammensætninger
JP2005075752A (ja) * 2003-08-29 2005-03-24 Nippon Inst For Biological Science 豚繁殖・呼吸障害症候群用ワクチン製剤
DE10351644A1 (de) * 2003-11-05 2005-06-09 Bayer Technology Services Gmbh Verfahren zur Herstellung von lagerstabilen multiplen Emulsionen
JP2008503563A (ja) * 2004-06-23 2008-02-07 ロレアル 敏感及び／又は乾燥肌の予防及び／又は処置に有用な方法及び組成物
FR2872047B1 (fr) * 2004-06-23 2007-06-15 Oreal Composition pour peaux sensibles associant cation mineral et probiotique(s)
FR2955776A1 (fr) 2010-02-01 2011-08-05 Seppic Sa Utilisation d'une huile minerale specifique pour la fabrication d'un nouveau adjuvant
FR2955775B1 (fr) 2010-02-01 2012-05-04 Seppic Sa Adjuvant pour la preparation de compositions vaccinales destinees a la prevention contre les coccidioses
FR2956403B1 (fr) 2010-02-17 2014-10-17 Afssa Antigenes polypeptidiques de trichinella, et leurs applications
EP3119430A1 (en) * 2014-03-17 2017-01-25 GlaxoSmithKline Biologicals S.A. Oil/surfactant mixtures for self-emulsification
WO2018057467A1 (en) * 2016-09-20 2018-03-29 Kansas State University Research Foundation Epizootic hemorrhagic disease vaccine
CN108324940B (zh) * 2018-03-19 2020-07-07 中国医学科学院医学生物学研究所 甘油-3-磷酸的应用、含有甘油-3-磷酸的佐剂和疫苗剂
CN111658611B (zh) * 2020-04-13 2021-06-01 四川大学 一种基于微乳的疫苗递送系统及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925544A (en) * 1971-07-12 1975-12-09 Univ Southern Illinois Bovine vaccines and methods of making and using same
US4186194A (en) 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4073743A (en) * 1975-04-17 1978-02-14 Merck & Co., Inc. Process for preparing an emulsion
US4720386A (en) * 1976-11-24 1988-01-19 Mccollester Duncan L Vaccine and method for immunotherapy of neoplastic disease
LU77364A1 (no) * 1977-05-18 1979-01-19
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
DE3416609A1 (de) * 1984-05-05 1985-11-07 Degussa Ag, 6000 Frankfurt 2-amino-3-ethoxycarbonylamino-6-(p-fluor-benzylamino)- pyridin-gluconat und pharmazeutische zubereitungen, die diese substanz enthalten
US4746742A (en) * 1985-11-28 1988-05-24 Toho Yakuhin Kogyo Kabushiki Kaisha Analogs of nonreducing monosaccharide moiety of lipid A
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US4976954A (en) 1986-12-02 1990-12-11 Purdue Research Foundation Anticariogenic compositions
FR2619718B1 (fr) 1987-09-02 1991-07-12 Medibrevex Nouvelles formes galeniques de beta-2-mimetiques pour administration par voie per- et sublinguale
FR2649013B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
US5393791A (en) 1990-07-19 1995-02-28 Helena Chemical Company Homogeneous, essentially nonaqueous adjuvant compositions with buffering capability
FR2672495B1 (fr) * 1991-02-08 1995-10-20 Vacsyn France Sa Compositions immunomodulatrices, a base de produits comportant au moins un groupe phosphate ou sulfate, et un gel d'un compose d'aluminium.
FR2674755B1 (fr) * 1991-04-05 1995-02-03 Thorel Jean Noel Nouvelles compositions medicamenteuses immunostimulatrices.
WO1992018147A1 (en) 1991-04-19 1992-10-29 Affinity Biotech, Inc. Convertible microemulsion formulations
US5656465A (en) 1994-05-04 1997-08-12 Therion Biologics Corporation Methods of in vivo gene delivery
FR2733151B1 (fr) * 1995-04-20 1997-05-23 Seppic Sa Composition therapeutique comprenant un antigene ou un generateur in vivo d'un compose comprenant une sequence d'acides amines
US5690942A (en) 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines

Also Published As

Publication number Publication date
DE69608962T2 (de) 2000-11-16
EP0825875A1 (fr) 1998-03-04
JP2002193841A (ja) 2002-07-10
US6274149B1 (en) 2001-08-14
DE69608962D1 (de) 2000-07-27
WO1996032964A1 (fr) 1996-10-24
ES2147924T3 (es) 2000-10-01
EP0825875B1 (fr) 2000-06-21
AU5696896A (en) 1996-11-07
AU695802B2 (en) 1998-08-20
BR9608067A (pt) 1999-01-26
JP3455226B2 (ja) 2003-10-14
US6251407B1 (en) 2001-06-26
CN1088599C (zh) 2002-08-07
US20010033845A1 (en) 2001-10-25
NO974837L (no) 1997-10-20
JPH11503743A (ja) 1999-03-30
FR2733151B1 (fr) 1997-05-23
US6610309B2 (en) 2003-08-26
CN1184431A (zh) 1998-06-10
KR19990007883A (ko) 1999-01-25
US20020164359A1 (en) 2002-11-07
US6342234B1 (en) 2002-01-29
FR2733151A1 (fr) 1996-10-25

Similar Documents

Publication Publication Date Title
NO974837L (no) Terapeutisk preparat omfattende et antigen eller en in vivo-generator for generering av en forbindelse som omfatter en aminosyre-sekvens
DK1093815T3 (da) Oral 2-methyl-thieno-benzodiazepinformulering
PT954293E (pt) Formulacoes para doses de libertacao controlada num tempo especifico e metodo de as preparar
DE69618786D1 (de) Wärmeerzeugende zahnpasta
EE03424B1 (et) Allergiavastase valguhüdrolüsaadipreparaadi valmistamise meetod
NO973612D0 (no) Nytt farmasöytisk preparat
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
DE69624112D1 (de) Azidfreier zweikammer-generator
AU7242994A (en) Model for testing immunogenicity of peptides
FI973002A0 (fi) Terapeuttinen yhdiste - rasvahappokonjugaatit
DE69605631D1 (de) Wechselstromerzeuger
DE69618752T2 (de) Resistzusammensetzung mit strahlungsempfindlichem Säuergenerator
DE69627436D1 (de) Generator
ID24596A (id) Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral
DE69400995D1 (de) Alpha-Hydroxysäuren enthaltendes kosmetisches Shampoos
NO973610D0 (no) Nytt farmasöytisk preparat
NO964612D0 (no) Fremgangsmåte for forankring av en strekkforankret plattform
NO973611D0 (no) Nytt farmasöytisk preparat
DE69629007D1 (de) Lasergenerator
BR9706301A (pt) Formulação química terapêutica para creme dental
SE9502503D0 (sv) New amino acid derivatives
IT1272941B (it) Emulsionanti per composizioni cosmetiche
FI960547A0 (fi) Adipiinihapon valmistusmenetelmä
BR7500159U (pt) Delineador modificado para prótese dentárias
KR970019551U (ko) 하프 공급전압(1/2vdd) 발생기

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application